Regencell Bioscience Holdings Limited operates as a holding company. The Company, through its subsidiaries, focuses on research, development, and commercialization of traditional medicine for the treatment of neurocognitive disorders and degeneration. Regencell Bioscience Holdings serves customers worldwide.